Cargando…

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?

Detalles Bibliográficos
Autores principales:	Anderson, Jeffrey L., May, Heidi, Knight, Stacey, Bair, Tami, Le, Viet, Muhlestein, J., Knowlton, Kirk, Horne, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091291/ http://dx.doi.org/10.1016/S0735-1097(21)04441-7

Ejemplares similares

Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

THE ROLE OF ABO BLOOD GROUP TYPING IN RISK STRATIFYING PATIENTS WITH THE NOVEL CORONAVIRUS 2019-NCOV
por: Shadid, Husam, et al.
Publicado: (2021)

A COMPARISON OF CARDIOVASCULAR OUTCOMES AMONG SARS-COV-2 POSITIVE PATIENTS, SARS-COV-2 NEGATIVE PATIENTS, AND A HISTORICAL COHORT
por: May, Heidi Thomas, et al.
Publicado: (2023)

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2023)

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry
por: Horne, Benjamin D, et al.
Publicado: (2022)

IMPACT OF THE COVID PANDEMIC ON DEPRESSIVE SYMPTOMS AND SEVERITY
por: May, Heidi Thomas, et al.
Publicado: (2023)

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled Trial
por: Horne, Benjamin D., et al.
Publicado: (2021)

Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial
por: Horne, Benjamin D., et al.
Publicado: (2023)

Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World Experience
por: Anderson, Jeffrey L., et al.
Publicado: (2022)

ROUTINE PERIODIC FASTING IS ASSOCIATED WITH A LOWER RISK OF INPATIENT HOSPITALIZATION FOR THE PRIMARY DIAGNOSIS OF HEART FAILURE FOLLOWING COVID-19 DIAGNOSIS
por: Horne, Benjamin Davies, et al.
Publicado: (2023)

A Small but Significantly Greater Incidence of Inflammatory Heart Disease Identified After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2
por: Knowlton, Kirk U, et al.
Publicado: (2021)

Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis
por: Muhlestein, Joseph B., et al.
Publicado: (2022)

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population
por: Muhlestein, Joseph B., et al.
Publicado: (2020)

SPORTS CLEARANCE FOLLOWING SARS-COV-2 INFECTION IN CHILDREN: DOES NONINVASIVE TESTING PREDICT ABNORMAL CARDIAC MRI?
por: Tejtel, Sara Kristen Sexson, et al.
Publicado: (2021)

THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021)

ASSOCIATION OF BLOOD VISCOSITY AND PROGNOSIS OF HOSPITALIZED COVID-19 PATIENTS
por: Choi, Daein, et al.
Publicado: (2022)

STEPWISE SCREENING OF PATIENTS REFERRED TO A COVID-19 CARDIOLOGY CLINIC FOR PERSISTENT CARDIOVASCULAR SYMPTOMS
por: Churchill, Austin, et al.
Publicado: (2022)

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
por: Le, Viet T., et al.
Publicado: (2023)

SOLUBLE P-SELECTIN, PLATELET ACTIVITY AND RISK OF MORBIDITY AND MORTALITY IN COVID-19
por: Mosarla, Ramya, et al.
Publicado: (2022)

COMPUTED ALGORITHMS TO IDENTIFY SUBTYPES OF ACUTE MYOCARDIAL INJURY IN ACUTE COVID-19
por: Satterfield, Benjamin, et al.
Publicado: (2022)

ELEVATED BLOOD VISCOSITY PREDICTS A HIGHER MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19
por: Choi, Daein, et al.
Publicado: (2022)

NEW-ONSET ATRIAL FIBRILLATION DURING HOSPITALIZATION FOR COVID-19 PATIENTS WITHOUT PREEXISTING CARDIOVASCULAR DISEASE
por: Wang, Suwei, et al.
Publicado: (2021)

LONG TERM CMR CHARACTERIZATION OF ATHLETES RECOVERING FROM COVID-19 INFECTION AND RETURN TO PLAY
por: Wroblewski, Jennifer, et al.
Publicado: (2022)

THE ASSOCIATION OF STRUCTURAL INEQUITIES AND RACE WITH OUT-OF-HOSPITAL SUDDEN DEATH DURING THE COVID-19 PANDEMIC
por: Makker, Parth, et al.
Publicado: (2021)

IMPACT OF COVID-19 ON DAILY STEP COUNTS AND ASSOCIATIONS WITH SOCIODEMOGRAPHICS AND MENTAL HEALTH: INSIGHTS FROM ALL OF US RESEARCH PROGRAM
por: Desine, Stacy, et al.
Publicado: (2023)

INCREASED INPATIENT MORTALITY FOR CARDIOVASCULAR PATIENTS DURING THE FIRST WAVE OF THE COVID-19 EPIDEMIC IN NEW YORK
por: Makker, Parth, et al.
Publicado: (2021)

STATIN USE MAY BE ASSOCIATED WITH DECREASED SEVERITY OF COVID-19
por: Shadid, Husam, et al.
Publicado: (2021)

RECOVERY OF CARDIAC FUNCTION FOLLOWING COVID-19 INFECTION: ECHOVID-19 - A LONGITUDINAL COHORT STUDY
por: Lassen, Mats Højbjerg, et al.
Publicado: (2021)

OBESITY, INFLAMMATION, AND OUTCOMES IN COVID-19
por: Padalia, Kishan, et al.
Publicado: (2021)

CARDIOVASCULAR DISEASE AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19: A STOP-COVID ANCILLARY
por: Meloche, Chelsea, et al.
Publicado: (2021)

CARDIAC COMPLICATIONS FOLLOWING REPEATED DOSES OF COVID-19 VACCINES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Le, Trang Thi Bich, et al.
Publicado: (2023)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

THE IMPLICATIONS OF COVID-19 VACCINATION ON HOSPITALIZATIONS AND CLINICAL OUTCOMES
por: Case, Brian, et al.
Publicado: (2022)

CLINICAL PREDICTORS OF COAGULOPATHY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 DISEASE
por: Derbas, Laith, et al.
Publicado: (2021)

RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH COVID-19 INFECTION: A META-ANALYSIS
por: Mazur, Jan, et al.
Publicado: (2021)

BIOMARKERS OF INFLAMMATION AND OUTCOMES OF PATIENTS HOSPITALIZED FOR COVID-19: THE INTERNATIONAL STUDY OF INFLAMMATION IN COVID-19
por: Meloche, Chelsea, et al.
Publicado: (2021)

FULLY AUTOMATED ANALYSIS OF CARDIAC POINT OF CARE ULTRASOUND: FEASIBILITY AND CLINICAL RELEVANCE IN COVID-19 PATIENTS.
por: Hawkes, Will, et al.
Publicado: (2022)

STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
por: Knight, Stacey, et al.
Publicado: (2015)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
por: Cutler, Michael J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o88i0d5h69b34kvij5096oa9tf